Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Livzon Pharmaceutical Group Inc (000513)

Shenzhen
Currency in CNY
Disclaimer
37.55
-0.03(-0.08%)
Closed
Earnings results expected today
Fair Value
Unlock Value
Day's Range
37.0938.09
52 wk Range
31.7240.58
Bid/Ask
37.55 / 37.56
Prev. Close
37.58
Open
37.36
Day's Range
37.09-38.09
52 wk Range
31.72-40.58
Volume
4,444,286
Average Vol. (3m)
5,486,841
1-Year Change
7.19%
Shares Outstanding
921,835,548
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
39.92
Upside +6.31%

People Also Watch

16.92
000975
+0.96%
18.54
601168
+2.04%
30.27
002422
+1.24%
4.63
600282
+0.22%
7.84
600919
-0.13%
How do you feel today about 000513?
Vote to see community's results!
or

Livzon Pharmaceutical Group Inc Company Profile

Livzon Pharmaceutical Group Inc. researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People’s Republic of China. The company offers drug preparation products, including Ilaprazole enteric coated tablets to treat duodenal ulcers and reflux esophagitis; Laprazole sodium for injection to treat peptic ulcer hemorrhage; Leuprorelin Acetate Microspheres for injection to treat endometriosis, hysteromyoma, premenopausal breast and prostate cancer, and central precocious puberty; and Urofollitropin for injection to treat anovulation and sufferers. It also provides Perospirone hydrochloride tablets to treat schizophrenia; Shenqi Fuzheng Injection to treat weakness and tiredness, lassitude, spontaneous sweating, and vertigo, as well as for treating lung and stomach cancer; anti-viral granules used for clearing heat, eliminating dampness, cooling blood, and detoxifying to treat upper respiratory tract infection and influenza; Tocilizumab injection to treat rheumatoid arthritis; and Recombinant SARSCoV-2 fusion protein vaccine used to prevent diseases caused by SARS-CoV-2 infection. In addition, the company offers diagnostic reagents, such as rapid test for 2019-nCoV antigen, used for the suspected cases of COVID-19 virus; antinuclear antibody test kit, used for the detection of common anti-nuclear and anti-antibodies in the autoimmune diseases; nucleic acid test kits for human immunodeficiency virus type 1; interferon-gamma release assays test kits, used to determine whether the human body is infected with Mycobacterium tuberculosis; diagnostic kit for IgM/IgG antibody to coronavirus; and rapid test for mycoplasma pneumoniae IgM antibody. Further, it provides biochemical drugs, microbiological preparations, biologic products, Chinese drug preparations and pharmaceutical raw materials, and antibiotics. The company was founded in 1985 and is headquartered in Zhuhai, China.

Employees
9005
Market
China
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.